{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T09:33:55Z","timestamp":1792316035334,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":4214,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1046\/j.1524-4733.2002.51083.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T23:33:56Z","timestamp":1047512036000},"page":"35-43","source":"Crossref","is-referenced-by-count":30,"title":["The Incidence and Cost of Hospitalization for 5-FU Toxicity among Medicare Beneficiaries with Metastatic Colorectal Cancer"],"prefix":"10.1016","volume":"5","author":[{"given":"Thomas E.","family":"Delea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Vera-Llonch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Edelsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"McGarry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Anton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Ulcickas-Yood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerry","family":"Oster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1524-4733.2002.51083.x_bib10","series-title":"Cancer Facts and Figures 1997","author":"American Cancer Society","year":"1997"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib20","series-title":"NIH Publication No. 96-691","author":"Cancer Rates and Risks","year":"1996"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib30","series-title":"Cancer Data Base: Annual Review of Patient Care 1995","article-title":"Colorectal cancer","author":"Steele","year":"1995"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib40","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1200\/JCO.1991.9.11.1967","article-title":"Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer","volume":"9","author":"Poon","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib50","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1200\/JCO.1989.7.10.1407","article-title":"Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma","volume":"7","author":"Poon","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib60","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1200\/JCO.1988.6.3.469","article-title":"A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma","volume":"6","author":"Erlichman","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib70","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1200\/JCO.1989.7.10.1437","article-title":"Superiority of sequential methotrexate, fluorouracil and leucovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: a randomized trial","volume":"7","author":"Nordic Gastrointestinal Tumor Adjuvant Therapy Group","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib80","first-page":"935","article-title":"Prospective randomized trial of 5-fluorouracil versus 5-fluorouracil plus levamisole in the treatment of metastatic colorectal cancer: a Hoosier Oncology Group Trial","volume":"4","author":"Bandealy","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib90","first-page":"1136","article-title":"Chemotherapy for colorectal cancer","volume":"330","author":"Moertel","year":"1994","journal-title":"N\u2009Eng J Med"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib100","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1200\/JCO.1998.16.1.301","article-title":"Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer","volume":"16","author":"Meta-Analysis Group in Cancer","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib110","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00000421-199806000-00004","article-title":"A prospective randomized study comparing high-and low-dose leucovorin combined with same-dose 5-fluorouracil in advanced colorectal cancer","volume":"21","author":"Ychou","year":"1998","journal-title":"Am J Clin Oncol"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib120","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1200\/JCO.1997.15.2.808","article-title":"Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French Intergroup Study","volume":"15","author":"de Gramont","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib130","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1200\/JCO.1997.15.11.3320","article-title":"Prospectively randomized North Central Cancer Treatment Group Trial of intensive-course fluorouracil combined with the l-isomer of intravenous leucovorin, oral leucovorin, or intravenous leucovorin for the treatment of advanced colorectal cancer","volume":"15","author":"Goldberg","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib140","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1023\/A:1008263516099","article-title":"A prospective randomized trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer","volume":"8","author":"Ross","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib150","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1200\/JCO.1997.15.3.908","article-title":"Fluorouracil plus racemic leucovorin versus fluorouracil combined with the pure l-isomer of leucovorin for the treatment of advanced colorectal cancer: a randomized phase III study","volume":"15","author":"Scheithauer","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib160","first-page":"2682","article-title":"Fluorouracil and leucovorin with or without interferon alfa-2b in advanced colorectal cancer: analysis of a prospective randomized phase III trial","volume":"14","author":"Kosmidis","year":"1996","journal-title":"Hellenic Cooperative Oncology Group. J Clin Oncol"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib170","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/1120009X.1993.11739210","article-title":"Folinic acid does improve 5-fluorouracil activity in vivo. Results of a phase III study comparing 5-fluorouracil to 5-fluorouracil and folinic acid in advanced colon cancer patients","volume":"5","author":"Bobbio-Pallavicini","year":"1993","journal-title":"J Chemother"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib180","first-page":"607","article-title":"Weekly regimen of 5-FU + intermediate dose folinic acid in the treatment of advanced colorectal cancer","volume":"12","author":"Martoni","year":"1992","journal-title":"Anticancer Res"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib190","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1200\/JCO.1990.8.3.491","article-title":"Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients with previously unexposed to chemotherapy","volume":"8","author":"Doroshow","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib200","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1200\/JCO.1990.8.2.313","article-title":"Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer","volume":"8","author":"Kemeny","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib210","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.1989.7.10.1419","article-title":"The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial","volume":"7","author":"Gastrointestinal Tumor Study Group","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib220","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1200\/JCO.1989.7.4.425","article-title":"A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a mid-Atlantic oncology program study","volume":"7","author":"Lokich","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib230","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.1989.7.10.1419","article-title":"The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial","volume":"7","author":"Petrelli","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib240","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1200\/JCO.1989.7.10.1427","article-title":"Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil and leucovorin: a randomized trial of the Northern California Oncology Group","volume":"7","author":"Valone","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib250","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1200\/JCO.1998.16.2.418","article-title":"Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: Results of a randomized trial in patients with advanced colorectal cancer","volume":"16","author":"K\u00f6hne","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib260","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1200\/JCO.1988.6.4.642","article-title":"A prospective randomized trial of fluorouracil versus fluorouracil plus cisplatin in the treatment of metastatic colorectal cancer: a Hoosier Oncology Group trial","volume":"6","author":"Loehrer","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib270","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1200\/JCO.1987.5.2.272","article-title":"5-Fluorouracil and folinic acid in the treatment of metastatic colorectal cancer: a randomized comparison","volume":"5","author":"Budd","year":"1987","journal-title":"A Southwest Oncology Group Study. J Clin Oncol"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib280","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1200\/JCO.1987.5.10.1559","article-title":"A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma","volume":"5","author":"Petrelli","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib290","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1200\/JCO.1994.12.1.14","article-title":"Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer","volume":"12","author":"Buroker","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib300","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/1097-0142(19950101)75:1<11::AID-CNCR2820750104>3.0.CO;2-N","article-title":"Age and sex are independent predictor of 5-fluorouracil toxicity. Analysis of a large-scale phase III trial","volume":"75","author":"Stein","year":"1995","journal-title":"Cancer"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib310","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/(SICI)1097-0142(19960815)78:4<918::AID-CNCR32>3.0.CO;2-W","article-title":"The National Cancer Data Base report on colon cancer","volume":"78","author":"Jessup","year":"1996","journal-title":"Cancer"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib320","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/1097-0142(19950201)75:3<775::AID-CNCR2820750305>3.0.CO;2-D","article-title":"A national population-based study of incidence of colorectal cancer and age. Implications for screening older Americans","volume":"75","author":"Cooper","year":"1995","journal-title":"Cancer"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib330","first-page":"283","article-title":"Racial disparity in the incidence and case-fatality of colorectal cancer: analysis of 329 United States counties","volume":"6","author":"Cooper","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib340","doi-asserted-by":"crossref","first-page":"582","DOI":"10.2105\/AJPH.86.4.582","article-title":"Surgery for colorectal cancer: race-related differences in rates and survival among Medicare beneficiaries","volume":"86","author":"Cooper","year":"1996","journal-title":"Am J Public Health"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib350","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/oxfordjournals.aje.a009095","article-title":"Ability of Medicare claims data and cancer registries to identify cancer cases and treatment","volume":"145","author":"McClish Penberthy","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib360","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1002\/1097-0142(19940501)73:9<2417::AID-CNCR2820730927>3.0.CO;2-L","article-title":"Measuring the incidence of cancer in elderly Americans using Medicare claims data","volume":"73","author":"McBean","year":"1994","journal-title":"Cancer"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib370","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00005650-199308000-00006","article-title":"Potential for cancer-related health services research using a linked Medicare-tumor registry database","volume":"31","author":"Potosky","year":"1993","journal-title":"Med Care"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib380","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Statist Assoc"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib390","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib400","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables (with discussion)","volume":"Ser. B 34","author":"Cox","year":"1972","journal-title":"J Royal Statist Soc"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib410","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2307\/2533947","article-title":"Estimating medical costs from incomplete follow-up data","volume":"53","author":"Lin","year":"1997","journal-title":"Biometrics"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib420","volume":"1 and 2","author":"SAS Institute Inc","year":"1989"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib430","volume":"Vol. 1","author":"ICD-9-CM","year":"1993"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib440","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/00001813-199608000-00001","article-title":"Colorectal cancer\u2014an undertreated disease","volume":"7","author":"Kemeny","year":"1996","journal-title":"Anticancer Drugs"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib450","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/00005650-199112000-00005","article-title":"Accuracy of Medicare claims data for estimation of cancer incidence and resection rates among elderly Americans","volume":"29","author":"Whittle","year":"1991","journal-title":"Med Care"},{"key":"10.1046\/j.1524-4733.2002.51083.x_bib460","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/(SICI)1097-0142(19980815)83:4<673::AID-CNCR7>3.0.CO;2-L","article-title":"Use of Medicare claims data to measure county-level variations in the incidence of colorectal carcinoma","volume":"83","author":"Cooper","year":"1998","journal-title":"Cancer"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109830151060006X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109830151060006X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T17:36:39Z","timestamp":1733592999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109830151060006X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["S109830151060006X"],"URL":"https:\/\/doi.org\/10.1046\/j.1524-4733.2002.51083.x","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}